Lee McCracken, an industry veteran, has been appointed chief executive officer of Gensignia Life Sciences Inc, a wholly-owned subsidiary of the London-based molecular diagnostics company Gensignia Ltd. Gensignia Life Sciences is located in San Diego, California and is the site of the company’s laboratory operations.
Mr McCracken has worked for more than 20 years in the pharmaceutical, biotechnology, diagnostics and venture capital industries. He was most recently president and CEO of Pathwork Diagnostics (now Response Genetics Inc) which developed an FDA-approved cancer diagnostic. Mr McCracken holds an MBA from the Anderson School of Management at the University of California, Los Angeles.
Gensignia announced the appointment on 30 May 2014.
Copyright 2014 Evernow Publishing Ltd